Tandem Investment Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-750
Closed -$212K 82
2025
Q3
$212K Hold
750
0.01% 78
2025
Q2
$209K Buy
+750
New +$212K 0.01% 67
2025
Q1
Sell
-909
Closed -$237K 71
2024
Q4
$237K Sell
909
-746
-45% -$221K 0.01% 70
2024
Q3
$534K Buy
1,655
+857
+107% +$280K 0.02% 57
2024
Q2
$249K Sell
798
-52
-6% -$15.3K 0.01% 70
2024
Q1
$242K Buy
+850
New +$249K 0.01% 76
2023
Q4
Sell
-750
Closed -$202K 81
2023
Q3
$202K Buy
+750
New +$187K 0.01% 79
2021
Q4
Sell
-998
Closed -$212K 83
2021
Q3
$212K Buy
998
+6
+0.6% +$1.38K 0.02% 74
2021
Q2
$242K Buy
992
+103
+12% +$25.3K 0.02% 65
2021
Q1
$221K Sell
889
-97
-10% -$23.1K 0.02% 64
2020
Q4
$227K Buy
986
+19
+2% +$4.38K 0.02% 70
2020
Q3
$246K Buy
967
+20
+2% +$4.96K 0.03% 63
2020
Q2
$223K Buy
+947
New +$216K 0.03% 65

Other funds holding AMGN

Tandem Investment Advisors's AMGN Position: Q4 2025 in Review

Tandem Investment Advisors sold out of Amgen (AMGN) in Q4 2025, closing a stake of 750 shares — an estimated $212K sold.

Tandem Investment Advisors first reported a position in AMGN in Q2 2020 and held it in 13 quarters. The position peaked at $534K in Q3 2024. 3,091 funds tracked by Wall St. Rank hold AMGN as of Q4 2025.

  • Tandem Investment Advisors reported no remaining Amgen position as of Q4 2025 after selling out during the quarter.
  • Tandem Investment Advisors sold 750 Amgen shares in Q4 2025, an estimated $212K.
  • Tandem Investment Advisors first reported a position in Amgen in Q2 2020 and held it in 13 quarters.
  • Tandem Investment Advisors's Amgen position peaked at $534K in Q3 2024.
  • 3,091 funds tracked by Wall St. Rank held Amgen as of Q4 2025.

Based on Tandem Investment Advisors's 13F filing for Q4 2025, filed 9 Feb 2026.